Home » January - December 1999 Follow-On Public Offerings
January - December 1999 Follow-On Public Offerings
Jan. 1, 2000
Company (Symbol)
Offer Date
Number Shares/ Units (M)*
Price Per Share/ Unit ($)
Gross ($M)*
Net ($M)
Shares Out (M)
Post- Offering Market Cap ($M)@
Lead Under- Writer**
Other Under- Writers
PowderJect Pharmaceuticals plc1 (LSE:PJP; UK)***
2/1
8.0S
11.06
88.8
85.8
72.4
800
RF
¿
Abgenix Inc. (ABGX)
3/4
3.2S
15
48.5
48.1
14.8
222
BRS
LB, PGE
ChiRex Inc.2 (CHRX)
3/19
2.9S
19
54.6
51.1
14.8
281.2
CSFBC
DRW, HQ, LM
Cerus Corp. (CERS)
3/31
2.2S
21
46.2
43.9
11.6
243.6
MSC
BTAB, SGC
QLT Phototherapeutics Inc. (QLTI)
4/29
3.16S
43.63
138
131.1
31.5
1374.3
CIBC
BTAB, INGB, NB, WDR
AltaRex Corp. (TSE:AXO)***
5/7
39.1S
0.34
13.3
112.1
55.6
18.9
FMSL
HSBC
Synsorb Biotech Inc. (SYBB; TSE: SYB)***
5/13
10.35S
1.17
12.1
11.3
31.2
36.5
TDS
HSBC, LOM, CCC
Trimeris Inc. (TRMS)
5/27
2.9S
11.75
33.8
31.4
13.6
160
INGB
BRS, SGC
Alliance Pharmaceutical Corp. (ALLP)
6/11
9.5
2.45
23.3
22.1
33.2
81
CR (placement agent)
¿
Ribozyme Pharmaceuticals Inc. (RZYM)
7/7
1.8S
3.5
6.3
5.8
11
38.5
HQ (placement agent)
¿
Angiotech Pharmaceuticals Inc. (TSE:ANP)***
7/9
1.5S
7.81
11.7
10.4
13.3
103.9
LBG
LOM
Alizyme plc3 (LSE:AZM)***
7/21
7.0U
1.19
8.4
7.9
49
58.3
N/A
¿
NeoTherapeutics Inc. (NEOT)
8/3
1.15S
9.38
10.8
10.2
7.8
73.2
JC
¿
Shaman Pharmaceuticals Inc. (OTC BB:SHMN)
8/24
0.7S
15
10.7
10.2
3.1
46.5
¿
¿
Pharmacyclics Inc. (PCYC)
9/24
2.645S
38.75
102.5
96.2
15
581.3
MSDW
HQ, PGE
Connetics Corp. (CNCT)
10/1
4.92S
4.75
29.52
21.5
26.4
125.4
WDR
HQ, RJA
CV Therapeutics Inc. (CVTX)
10/6
5.75S
12
69
64.4
18.1
217.2
DLJ
BRS, JPM, SGC
Emisphere Technologies Inc. (EMIS)
10/28
2.3S
11
25.3
23.5
14.5
159.5
HQ
¿
Genentech Inc. (NYSE:DNA)
10/20
22S
143.5
$3,157
¿#
130.5
$18,726.8
JPM
GSC, ML, WDR, RS
Invitrogen Corp. (IVGN)
10/27
2.4S
25
60
57
18.9
472.5
DLJ
HQ, USBPJ, DRW
Magainin Pharmaceuticals Inc. (MAGN)
10/15
4S
11.125
4
4
26.9
30.3
Shares directly offered by the company
Vion Pharmaceuticals Inc. (VION)
10/26
2.5S
5
12.5
11.9
18.2
91
BMC
¿
ViroPharma Inc. (VPHM)
10/22
3.45S
19
65.6
61.4
15.04
285.8
MSDW
USBPJ
Advanced Tissue Sciences Inc. (ATIS)
11/10
3.75U
4
15
15
53
212
Shares directly offered by the company
Alexion Pharmaceuticals Inc. (ALXN)
11/30
3.415S
14
47.8
44.5
14.7
205.8
USBPJ
HQ
BioCryst Pharmaceuticalsj Inc. (BCRXj
11/3
2S
25.25
50.5
46.8
17.2
434.3
SSB
HQ, RJA
Ilex Oncology Inc. (ILXO)
11/23
4.2S
14
58.8
55.3
21.5
301
CIBC
PVHG, USBPJ
ImClone Systems Inc. (IMCL)
11/19
3.16S
32
101.2
94.3
28.8
921.6
MSDW
ML, PVHG, WDR
Inex Pharmaceuticalsj Corp. (TSE:IEX)
11/23
4.92S
2.55
12.6
11.9
21.9
55.8
NB
RBC, YS
Progenics Pharmaceuticals Inc. (PGNX)
11/19
2.3S
19
43.7
41.1
11.9
226.1
CIBC
RS, PVH, GKMC, PZC
January December 1999 Follow-On TOTAL: $4,361.52
Note: * Number of shares (or units) sold in the offering includes those sold to satisfy overallotment options, in full or in part, when disclosed. Likewise, gross proceeds include revenues for the sale of shares (or units) to satisfy overallotment options, in full or in part, where applicable.
Note: ** See Underwriters¿ Key on Page 45
Note: ***Converted to U.S. dollars based on exchange rate at the time of the offering.